title: Mitochondriopathy, blepharospasm, and treatment with botulinum toxin.
authors.forename: K R
authors.initials: KR
authors.lastname: Müller-Vahl
authors.forename: H
authors.initials: H
authors.lastname: Kolbe
authors.forename: R
authors.initials: R
authors.lastname: Egensperger
authors.forename: R
authors.initials: R
authors.lastname: Dengler
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001764:Blepharospasm / Q000150:complications* / Q000188:drug therapy*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D005260:Female; D007839:Functional Laterality; D006801:Humans; D008875:Middle Aged; D008931:Mitochondria, Muscle / Q000473:pathology / Q000648:ultrastructure; D017240:Mitochondrial Myopathies / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D018482:Muscle, Skeletal / Q000473:pathology* / Q000648:ultrastructure; D009460:Neurologic Examination
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins